ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Zeneca Says NSABP Was Tardy In Reporting Uterine Cancer Deaths

June 24, 1994

Also NCI Cancels von Eschenbach’s Farewell Party, Returns Gift Contributions Amid Ethics Questions.

May 19, 2006

Be More Aggressive On National Issues, ASCO Urged

May 20, 1977

Cancer Policy: President’s Cancer Panel Issues Statement On National Cancer Program

September 17, 1999

Specter Remains Chairman Of Labor-HHS Subcommittee.

February 2, 2001

Also in this 8-page issue: NCI informatics project caBIG will “rapidly accelerate” cancer research, von Eschenbach says.

March 12, 2004